Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 17, 2024

SELL
$30.71 - $45.71 $9.97 Million - $14.8 Million
-324,692 Closed
0 $0
Q4 2021

May 17, 2024

BUY
$37.06 - $47.11 $60,296 - $76,647
1,627 Added 0.5%
324,692 $13.8 Billion
Q3 2021

May 17, 2024

BUY
$40.26 - $57.37 $58,457 - $83,301
1,452 Added 0.45%
323,065 $14.3 Billion
Q2 2021

May 17, 2024

BUY
$54.88 - $79.29 $185,220 - $267,603
3,375 Added 1.06%
321,613 $18.3 Billion
Q1 2021

May 17, 2024

BUY
$70.65 - $96.76 $237,030 - $324,629
3,355 Added 1.07%
318,238 $23.8 Billion
Q4 2020

May 17, 2024

BUY
$58.41 - $89.06 $89,717 - $136,796
1,536 Added 0.49%
314,883 $27.2 Billion
Q3 2020

May 17, 2024

BUY
$41.13 - $62.45 $104,182 - $158,185
2,533 Added 0.81%
313,347 $19.2 Billion
Q2 2020

May 17, 2024

BUY
$25.95 - $43.15 $55,091 - $91,607
2,123 Added 0.69%
310,814 $12.9 Billion
Q1 2020

May 17, 2024

BUY
$26.15 - $77.24 $8.07 Million - $23.8 Million
308,691 New
308,691 $8.87 Billion
Q4 2019

May 17, 2024

BUY
$60.18 - $154.77 $11.4 Million - $29.4 Million
190,000 New
190,000 $13.7 Billion

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $323M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Portfolio

Follow Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A., based on Form 13F filings with the SEC.

News

Stay updated on Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. with notifications on news.